Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' ( le were removed.Calculations based on ...)

Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy'

le were removed. Calculations based on the original data indicate that children with autism "were 71% more likely to have been exposed to RhIg in utero than their non-ASD siblings," according to the SafeMinds analysis.

NAA's Fournier points out that the RhIg study fits a recurring pattern for thimerosal research with drug company/researcher ties. Manipulation of data to reach a desired conclusion was seen in CDC studies conducted in 2000 showing a relationship between thimerosal-containing vaccines and a range of adverse neurological effects including autism. The data was manipulated to lower the relative risk factor before publication in the journal Pediatrics in 2004. Lead investigator Dr. Thomas Verstraeten left the CDC to work for vaccine maker Glaxo-Smith-Kline in 2001 while the data alterations were ongoing, but his employment was not disclosed by the journal. Likewise, Dr. Michael Pichichero, an Eli Lilly-funded researcher and holder of numerous vaccine patents, tried to clear thimerosal as harmful by conducting a blood mercury evaluation after infant vaccination which missed peak blood levels, had a sample size too small to detect susceptible subgroups, and failed to address implications of the findings for long term mercury deposition in the brain. His industry ties were not disclosed by the journal, The Lancet.

"While this latest RhIg effort is the best science drug money can buy," points out Ms. Fournier, "NAA feels that the public and families with autism deserve better quality studies. This is a critical product safety issue." RhIg is given to approximately 15% of all pregnant women.

To read the entire analysis, go to http://www.safeminds.org. For more about autism, visit http://www.nationalautism.org.

Contacts:

Rita Shreffler (Nixa, MO) 401-632-6452

Wendy Fournier (Portsmouth, RI) 401-632-7523<
'"/>

Page: 1 2 3
Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
3. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
4. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
5. Myriad Genetics Presents Tumor Origin Technology at AACR
6. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
7. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
8. Myriad Genetics Presents Azixas Mode of Action at AACR
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
11. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology

Post Your Comments:

(Date:11/25/2009)...e-FirstCall/--ERT(Nasdaq: ERES ),announcedtodaytha...andKeithSchneck,theCompany,sExecutiveVicePresident...ffrayHealthCareConferenceat1:30PMESTonDecember1,20...yaccessthepresentationbyvisitingtheCompany,scorpor...beaccessedat http://www.corporate-ir.net/ireye/con...

(Date:11/25/2009)...swire/--TheFDAgrantedtraditionalapprovalforINTELEN...transcriptaseinhibitor(NNRTI).INTELENCEistheonlyNN...cedadultswhoareexperiencingvirologicfailurewithHIV...ARV)agents.Thetraditionalapprovalisbasedon48-weekd...LENCEiscurrentlymarketedintheU.S.byTibotecTherapeu...

(Date:11/25/2009)...RNewswire/--AMPACFineChemicalsLLC(AFC),asubsidiary...edtodaythatitreceivedtheEnvironmentalResponsibilit...mentalSummit,sponsoredbytheCaliforniaManufacturers...nmentalAssociation(IEA)andtheChemicalIndustryCounc...estigiousawardavailablefromallthreeorganizationsan...

Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4 AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2 Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 1 Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 2 State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 1 State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 2 Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 1 Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 2

[0] ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 [0] U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)[0] AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit

...Call/ -- Repligen,Corporation announced today posi...uate the use of RG1068, synthetic human,secretin, ...c duct,structures by magnetic resonance imaging (M...y of detection of structural abnormalities,of the ...in,specificity, consistent with prior data and exp...

...0, 2007--Today, the,New England Journal of Medicin... of Merck,s cervical cancer vaccine, Gardasil,(Qua...8),Recombinant Vaccine). In the first study, Garda...al, vaginal and vulvar diseases,caused by the four..., HPV types 6, 11, 16, and 18. In the second study...

Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine

(Date:11/25/2009)...were treated with cisplatin-based chemotherapy had...side effects and Raynaud-like phenomena, than men ...to a new study published online November 25 in the...arianne Brydy, M.D., of the Department of Oncology..., and colleagues conducted a cross-sectional study...

(Date:11/25/2009)...ollaboration between UCLA engineers and physicians...lion Americans who suffer from peripheral arterial...rteries, peripheral arterial disease, or PAD, is a...ries reduce blood flow to the limbs. The condition...art attack and stroke, and its progression can res...

(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...

(Date:11/25/2009)...ent clinics to resume Monday, Nov. 30 , ... -- Centegra Health System is continuing to offer ... Centegra Primary Care (CPC) vaccination clinics s...clinics are at CPC sites in Huntley, Woodstock, Cr...: , From 4:30 to 7:30 p.m. Tuesday, ...

(Date:11/25/2009)...s, study finds , , WEDNESDAY, Nov. 25 (...mong the potential problems faced by long-term sur...cisplatin-based chemotherapy, a new study has foun...ated for unilateral testicular cancer between 1980...ucted from 1998 to 2002. , The researchers foun...

Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2 Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3 Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4

[0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects [1] Engineers, doctors at UCLA develop novel material that could help fight arterial disease [1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 [0] Long-Term Problems Linked to Testicular Cancer Chemo

...esearchers from the University of Chicago reportin... that nine out of ten doctors believe that it is a...However, only three out of four doctors encourage ...y mentions his or her religious beliefs and experi...

...rectile dysfunction is thought to be a common prob...ing the young, college aged men. But now, Dr. Naja...spital// in Chicago, went a step further in findin...llege-age males in Chicago to throw more light on ...

...espite all the rain, there seems to be enough shin...in cancer malignant melanoma, according to the Env...has embarked on a SunWise Program enabling free ki...tors apply different sunscreen and skin lotions on...

...f breast cancer in women has occurred because of t... seek remedy from a prevalent chemotherapy medicat...ovarian and lung cancers, is getting known for its...mutations are twenty times more receptive to carbo...

...ehavioral problems are more likely to occur in chi...ance abuse, domestic violence and mental health, o...in the Archives of General Psychiatry. // Th...at can contribute to behavior problems in children...

...espite the widespread belief that residents of nur...epartments in hospitals, //it has been found that ...are needs of the residents, even in the presence o...ty of Western Australia and the Royal Perth Hospit...

Other Medicine News:Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 2 Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 3 Health News:Maternal Difficulties Increase Risk of Behavior Problems in Children 2 Health News:Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds 2

Doctors' Response To Patients' Religious Beliefs Can Vary Sexual dysfunction does not spare even the young men.Seattle, a hub for malignant melanoma? Time To Get Sunwise!Carboplatin, Lung cancer drug may be useful in treating breast tumor Maternal Difficulties Increase Risk of Behavior Problems in Children Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

Medicine Products:

Normetanephrine, Plasma Norepinephrine, Random Urine Noradrenaline, Plasma Norephedrine

( le were removed.Calculations based on ...)Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy',Health